Vaccines Global Summit

The prevention of infections concerning the lungs and airways becomes possible by vaccines to diseases causing respiratory infections. Among them are flu, pneumonia, and COVID-19. By offering protection against respiratory infections such as influenza, pneumonia, and COVID-19, vaccines tend to reduce the incidence and severity of such infections among individuals and communities, it prevents serious complications among vulnerable populations, particularly elderly people, young children, and those who have chronic conditions.

Perhaps the most widely administrated vaccine in the realm of respiratory health is the flu vaccine. It's given annually and protects against the most common strains of the virus responsible for the flu, which are most associated with severe illness and death, mainly among the high-risk populations. Of course, reducing cases of the flu also prevents its complications, such as pneumonia, bronchitis, and exacerbations of chronic conditions like asthma and COPD.

Pneumococcal vaccines are one of the most crucial prevention methods against pneumonia as well as several diseases caused by the bacterium Streptococcus pneumoniae. Among the existing types of pneumococcal vaccines, there are two major vaccines: PCV13 and PPSV23, which offer protection against numerous strains of the bacteria. Vaccination is highly recommended for such persons that is elderly people, newborn children, and those with weakened immune systems. Severe respiratory complications, hospitalizations, and even death can be caused by pneumonia. A vaccine is therefore one necessary weapon in these circumstances.

The two newly introduced vaccines by Pfizer-BioNTech and Moderna have made tremendous strides in quelling the global pandemic by using innovative mRNA technology that provokes an immune response that prevents severe COVID-19 symptoms and complications, such as acute respiratory distress syndrome (ARDS), which is fatal.

Besides these, research is ongoing on vaccines against other respiratory diseases such as the respiratory syncytial virus, that also especially afflicts infants and older people. The reduction of infections, the decrease in complication, and then the improvement of lung health, vaccines against respiratory diseases are contributing to a decrease in hospitalizations and saving lives. Widespread immunization remains an essential part of the planning approaches used by public health professionals in protecting their communities against respiratory illnesses.